EGFR and hepatocellular carcinoma: In HCC, PTPRS is act as a metastasis suppressor, and loss of PTPRS can increase the activity of epidermal growth factor receptor (EGFR) signaling and promote the epithelial-mesenchymal transition (EMT) process in metastasis (38).